Amphastar Pharmaceuticals (AMPH) Shares Outstanding (2013 - 2026)

Amphastar Pharmaceuticals has reported Shares Outstanding (Entity) for 14 years, with the latest figure at $42.5 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 8.51% year-over-year to $42.5 million in Q2 2026; TTM through Jun 2026 was $42.5 million, a 8.51% decrease from a year earlier, with the FY2025 full-year figure at $45.6 million, down 4.14% from the prior year.
• Shares Outstanding (Entity) was $42.5 million for Q2 2026 at Amphastar Pharmaceuticals, down from $44.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $49.0 million in Q2 2022, with the low at $42.5 million in Q2 2026.
• Average Shares Outstanding (Entity) over 5 years is $47.5 million, with a median of $48.1 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) rose 2.17% in 2022, then slipped 8.51% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $48.1 million in 2022, then declined by 0.09% to $48.1 million in 2023, then slipped by 0.94% to $47.6 million in 2024, then slipped by 4.14% to $45.6 million in 2025, then declined by 6.82% to $42.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $42.5 million (Q2 2026), $44.6 million (Q1 2026), and $45.6 million (Q4 2025), per Business Quant data.